We recently showed how the Alb-R26Met genetic system is a unique tool to model: (a) the tumorigenic program, (b) the “proliferative-progenitor” HCC patient subgroup and (c) functionality of signalling alteration for drug discovery24. The gene discussed is ALB; the disease is hepatocellular carcinoma.